On the other hand, CYP1A2 and CYP2A6 could not be identified as hepatic autoantigens in the disease control groups consisting of patients with idiopathic AIH or patients with autoimmune rheumatic diseases [23]. Here, CYP2A6 is linked to autoimmune hepatitis.